Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist.
Eastwood P, Esteve C, González J, Fonquerna S, Aiguadé J, Carranco I, Doménech T, Aparici M, Miralpeix M, Albertí J, Córdoba M, Fernández R, Pont M, Godessart N, Prats N, Loza MI, Cadavid MI, Nueda A, Vidal B. Eastwood P, et al. Among authors: cordoba m. ACS Med Chem Lett. 2010 Dec 20;2(3):213-8. doi: 10.1021/ml100249e. eCollection 2011 Mar 10. ACS Med Chem Lett. 2010. PMID: 24900298 Free PMC article.
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
Aguilar N, Mir M, Grima PM, López M, Segarra V, Esteban L, Moreno I, Godessart N, Tarrasón G, Domenech T, Vilella D, Armengol C, Córdoba M, Sabaté M, Casals D, Domínguez M. Aguilar N, et al. Among authors: cordoba m. Bioorg Med Chem Lett. 2012 Dec 15;22(24):7672-6. doi: 10.1016/j.bmcl.2012.09.110. Epub 2012 Oct 11. Bioorg Med Chem Lett. 2012. PMID: 23141913
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.
Prat M, Buil MA, Fernández MD, Castro J, Monleón JM, Tort L, Casals G, Ferrer M, Huerta JM, Espinosa S, López M, Segarra V, Gavaldà A, Miralpeix M, Ramos I, Vilella D, González M, Córdoba M, Cárdenas A, Antón F, Beleta J, Ryder H. Prat M, et al. Among authors: cordoba m. Bioorg Med Chem Lett. 2011 Jun 1;21(11):3457-61. doi: 10.1016/j.bmcl.2011.03.096. Epub 2011 Apr 3. Bioorg Med Chem Lett. 2011. PMID: 21524581
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl amides as potent and long acting muscarinic antagonists.
Prat M, Buil MA, Fernández MD, Tort L, Monleón JM, Casals G, Ferrer M, Castro J, Gavaldà A, Miralpeix M, Ramos I, Vilella D, Huerta JM, Espinosa S, Hernández B, Segarra V, Córdoba M. Prat M, et al. Among authors: cordoba m. Bioorg Med Chem Lett. 2015 Apr 15;25(8):1736-1741. doi: 10.1016/j.bmcl.2015.02.065. Epub 2015 Mar 5. Bioorg Med Chem Lett. 2015. PMID: 25800115
Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
Taltavull J, Serrat J, Gràcia J, Gavaldà A, Córdoba M, Calama E, Montero JL, Andrés M, Miralpeix M, Vilella D, Hernández B, Beleta J, Ryder H, Pagès L. Taltavull J, et al. Among authors: cordoba m. Eur J Med Chem. 2011 Oct;46(10):4946-56. doi: 10.1016/j.ejmech.2011.07.054. Epub 2011 Aug 5. Eur J Med Chem. 2011. PMID: 21871695
Pharmacological characterization of a novel peptide inhibitor of the Keap1-Nrf2 protein-protein interaction.
Aparici M, Bravo M, Calama E, García-González V, Domènech T, Córdoba M, Roger I, Cortijo J, Góngora-Benítez M, Paradís-Bas M, Collins B, Davis AM, Albericio F, Puig C. Aparici M, et al. Among authors: cordoba m. Biochem Pharmacol. 2022 Oct;204:115226. doi: 10.1016/j.bcp.2022.115226. Epub 2022 Aug 24. Biochem Pharmacol. 2022. PMID: 36027928
Effect of propylene glycol on the skin penetration of drugs.
Carrer V, Alonso C, Pont M, Zanuy M, Córdoba M, Espinosa S, Barba C, Oliver MA, Martí M, Coderch L. Carrer V, et al. Among authors: cordoba m. Arch Dermatol Res. 2020 Jul;312(5):337-352. doi: 10.1007/s00403-019-02017-5. Epub 2019 Nov 30. Arch Dermatol Res. 2020. PMID: 31786711
336 results